Home › Bipolar Disorder › Missouri › O'Fallon
Bipolar Disorder clinical trials in O'Fallon, MO
4 studies for Bipolar Disorder are looking for participants at sites in and around O'Fallon (within about 30 miles). Open a study to see who can join and how to contact the study team.
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
RecruitingPhase 3
- Midwest Research Group 1, Saint Charles · 12 mi away
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
RecruitingPhase 3
- Midwest Research Group, Saint Charles · 12 mi away
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)
RecruitingPhase 3
- Psychiatric Care and Research Center, O'Fallon
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
RecruitingPhase 2
- Saint Charles Psychiatric Associates /ID# 279239, Saint Charles · 12 mi away
About Bipolar Disorder
Bipolar disorder is a mood disorder that can cause intense mood swings. It's also called manic depression. Learn about the types, symptoms, treatment, and more.
More about Bipolar Disorder on MedlinePlus
Bipolar Disorder trials in other cities
- Houston, TX10 studies
- Boston, MA7 studies
- New York City, NY7 studies
- Little Rock, AR6 studies
- Atlanta, GA6 studies
- Orange, CA5 studies
- Miami, FL5 studies
- Austin, TX5 studies
- Hialeah, FL5 studies
- Cambridge, MA5 studies
- Chicago, IL4 studies
- West Palm Beach, FL4 studies
Other studies in O'Fallon
- Obesity12 studies
- Overweight10 studies
- Prostate Cancer9 studies
- Major Depressive Disorder9 studies
- Non-Small Cell Lung Cancer8 studies
- Lung Cancer7 studies
- Breast Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Melanoma5 studies
- Colorectal Cancer5 studies
- Kidney Cancer (Renal Cell Carcinoma)5 studies
- Depression5 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.